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Summary
We present the results of extensive simulations that em-
ulate the development and distribution of linkage dise-
quilibrium (LD) between single-nucleotide polymor-
phisms (SNPs) and a gene locus that is phenotypically
stratified into two classes (disease phenotype and wild-
type phenotype). Our approach, based on coalescence
theory, allows an explicit modeling of the demographic
history of the population without conditioning on the
age of the mutation, and serves as an efficient tool to
carry out simulations. More specifically, we compare the
influence that a constant population size or an expo-
nentially growing population has on the amount of LD.
These results indicate that attempts to locate single dis-
ease genes are most likely successful in small and con-
stant populations. On the other hand, if we consider an
exponentially growing population that started to expand
from an initially constant population of reasonable size,
then our simulations indicate a lower success rate. The
power to detect association is enhanced if haplotypes
constructed from several SNPs are used as markers. The
versatility of the coalescence approach also allows the
analysis of other relevant factors that influence the
chances that a disease gene will be located. We show
that several alleles leading to the same disease have no
substantial influence on the amount of LD, as long as
the differences between the disease-causing alleles are
confined to the same region of the gene locus and as
long as each allele occurs in an appreciable frequency.
Our simulations indicate that mapping of less-frequent
diseases is more likely to be successful. Moreover, we
show that successful attempts to map complex diseases
depend crucially on the phenotype-genotype correlations
of all alleles at the disease locus. An analysis of lipo-
protein lipase data indicates that our simulations capture
the major features of LD occurring in biological data.
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Introduction
One of the important goals of modern genetics is to
understand the genetic basis of disease. A first step to-
ward that enterprise is locating the gene(s) involved in
the generation of a disease phenotype. Knowing the ge-
netics might lead to early diagnosis of risks and possibly
even to treatment. Particularly successful were attempts
to link RFLPs as markers to certain diseases (Gusella et
al. 1983). Although attempts to locate disease genes with
an underlying Mendelian segregation pattern were, by
and large, successful, little progress was made in the
analysis of complex diseases characterized by multiallelic
inheritance, low penetrance, and late onset (Collins et
al. 1997).
More recently, single-nucleotide polymorphisms
(SNPs), which are widely spread throughout the genome
(Cooper et al. 1985), have been considered to be suitable
tools for association studies (Collins et al. 1997; Lan-
degren et al. 1998). Much of today’s research effort goes
into the search for SNPs, to build a marker map that
spans the whole human genome. The ultimate aim is to
provide at least one SNP within each gene. Special ac-
tivities are under way to find diallelic markers that are
variable in most human populations, since such ubiq-
uitous markers facilitate sampling for large association
studies.
Different scenarios are imaginable in which SNPs are
helpful in locating a gene that produces phenotypically
different individuals. The best case occurs if one of the
alleles of the SNP creates the disease phenotype. How-
ever, this event is unlikely, since most genes are highly
polymorphic (Nickerson et al. 1998). The second-best
case, again very improbable, is absolute linkage between
the disease allele and the SNP. More likely are situations
in which we observe only a certain amount of linkage
disequilibrium (LD), which can be defined as the differ-
ence in the SNP allele-frequency distribution, condi-
tional on whether the wild-type allele or the disease allele
is present at the locus (Terwilliger et al. 1998). To eval-
uate the statistical significance of this difference, a test
method is required that compares an observed LD with
the LD distribution for an unlinked marker.
Here we assess the probability of detecting a strong
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association of one or more SNPs with a specified phe-
notype—for example, a disease. To this end, we simulate
the empirical distribution of LD between a disease gene
and one or more SNPs, compared with the distribution
in a sample of unaffected individuals. To explicitly take
into account the demographic history of the sample of
affected and unaffected individuals, a coalescent ap-
proach is applied (Hudson 1991; Donnelly and Tavare´
1995). The coalescent approach is much more efficient
than is simulation of the evolutionary history of a pop-
ulation forward through time.
Contrary to other studies (Thompson and Neel 1997;
Rannala and Slatkin 1998; Kruglyak 1999), we do not
assume that the mutation to a disease phenotype arose
at a fixed point in time, nor do we require that the
mutation occurred only once. Thus, our approach mim-
ics situations in which the disease shows allelic hetero-
geneity. Moreover, the coalescent process allows the ef-
ficient estimation of the amount of LD for disease
prevalences ranging from rare diseases to common dis-
eases, where prevalence reflects the frequency of chro-
mosomes carrying the disease locus in the population.
Therefore, we provide a unifying framework for deal-
ing with the evolutionary dynamics of marker-disease
association for a variety of population histories. Here
we present an approach that utilizes most of the known
properties of marker loci and disease loci, to evaluate
the chances of success of a case-control study.
Methods
For a case-control study, the coalescent theory traces
the common ancestry of the locus of interest in affected
and unaffected individuals. To reduce the number of
parameters, several simplifications are necessary.
First, we fix the prevalence of the disease and the
distribution of marker alleles. These distributions can be
estimated from given data. Second, we require that they
not change throughout time. Note that it is also possible
to include the assumption of a time-dependent distri-
bution of markers in our approach. However, this would
increase the variance in our results. At least for SNP
markers, the assumption of a constant distribution in
time seems to be justified by the fact that SNPs are poly-
morphic in all populations and that therefore they are
probably a result of an old mutation that predates the
origin of the populations. Moreover, it seems safe to
assume that there is little or no selection against the
disease allele, as long as we are dealing with common
diseases or with diseases having a late age at onset.
Simulation of the genealogy of a sample of size nW
(the number of wild-type chromosomes) and size nD (the
number of disease-carrying chromosomes) is carried out
in two successive steps. In the first step, a random ge-
nealogy of the entire sample of chromosomesn  nW D
is generated. Subsequently, the evolution of the SNP is
superimposed on the resulting genealogy, thus allowing
for mutations and recombination events. Finally, the
amount of linkage disequilibrium is computed. The fol-
lowing sections describe each step in more detail.
Building a Genealogy
Throughout the simulations, we consider a large
Wright–Fisher population. N(t) denotes the number of
wild-type chromosomes at time t (with respect to the
disease locus), with being the number of mutantf#N(t)
chromosomes (i.e., disease carriers) in the population,
where specifies the relative frequency of the affectedf 1 0
chromosomes with respect to the wild-type chromo-
somes. N(0) and define the number of wild-f#N(0)
type and disease chromosomes of the contemporary pop-
ulation. Note that the prevalence—that is, the number
of chromosomes carrying the disease locus of interest,
—is independent of the time t and is constant.f/(1 f )
Moreover, our experimental setup does not require that
the sample size nD reflect the frequency of the disease in
the population.
To produce a genealogy, we start with a sample of
size . Going back in time, we find that threen  nW D
events are possible: (1) the coalescence of two wild-type
chromosomes, (2) the coalescence of two disease chro-
mosomes, and (3) the mutation of a disease gene to a
wild-type gene. Thus, in cases (1) and (2), either the
sample of wild-type chromosomes is reduced by one or
the disease sample size is reduced by one, whereas, in
case (3), the wild-type sample is increased by one and
the disease sample is decreased by one. This event is
important in the generation of a genealogy that reflects
the common history (at the locus of interest) of the af-
fected and unaffected individuals. Since wild-type indi-
viduals and disease carriers represent different allelic
states at the disease locus, they cannot coalesce. Only
when a disease carrier mutates back to a wild type, going
back in time, is it possible for the two to coalesce. The
process stops when only one lineage is left, the most
recent common ancestor (MRCA) of the sample.
Figure 1 sketches the most simple situation: a constant
(CONST) population and a sample of wild-typen = 5W
chromosomes and chromosomes showing the dis-n = 5D
ease phenotype. In the wild-type population, the chro-
mosomes coalesce independently of the coalescence
events in the population of chromosomes carrying a dis-
ease allele. Wild-type and disease lineages can coalesce
only in the wild-type population—that is to say, the
chromosome carrying the disease allele has to mutate
back to the wild type (fig. 1, horizontal dashed line).
The two wild-type lineages can now coalesce to form
the MRCA. This intuitive description is made more pre-
cise in the following.
Let nW(t) and nD(t) be the number of wild-type and
disease chromosomes at time t that are ancestral to the
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Figure 1 Schematic view of the coalescent process in a CONST population consisting of wild-type chromosomes (left) and disease
allele–carrying chromosomes (right). From each contemporary group a sample size of five is drawn. Two chromosomes from a sample coalesce
at some point in time. Only individuals having the same allelic state can coalesce. Thus, to produce the MRCA of the entire sample, the ancestor
of the disease-carrying alleles must mutate back to a wild type (horizontal dashed line).
sample—that is, and . Then, ac-n (0) = n n (0) = nW W D D
cording to typical coalescence arguments (Hudson 1991;
Donnelly and Tavare´ 1995), the rate at which two wild
types or two disease chromosomes coalesce equals
1 n (t)Wr (t) = (1)W [ ]2N(t)
and
1 n (t)Dr (t) = . (2)D [ ]2fN(t)
Mutations from a disease gene to a wild type happen at
rate
r (t) = n (t)m , (3)M D
where m is the mutation rate of the disease gene per
generation. If we label the points in time when one of
the three events happened as and if,T = 0 ! T ! T ) ,0 1 2
for each i, we denote by the time intervalt = T  T ,i i1 i
of no change in the number of lineages, then the ti are
distributed approximately according to the following
probability-density function
[ ]p(t ) = r (T  t ) r (T  t ) r (T  t )i W i i D i i M i i
ti
[ ]exp  r (t) r (t) r (t) dt . (4) W D M{ }
Ti
If U is a unit uniform random variable, then solving
ti
[ ]U = exp  r (t) r (t) r (t) dt (5) W D M{ }
Ti
for ti will generate a variate randomly sampled from
equation (4) (Donnelly and Tavare´ 1995). For equation
(5), depending on the population demography, either
analytical solutions or numerical solutions are possible.
Once ti is found, the event that occurs at ti is deter-
mined according to the following probabilities:
r (T  t )M i iP = ; (6)mutation r (T  t ) r (T  t ) r (T  t )W i i D i i M i i
the probability for a coalescent in the wild-type sample
is
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Figure 2 Average LD between an SNP and a disease gene, as a function of the recombination rate. Different demographic histories were
simulated: CONST, REC-EXP, and OLD-EXP. The standard errors of the simulations are also shown.
r (T  t )W i iP = ;wild-type coalescent r (T  t ) r (T  t ) r (T  t )W i i D i i M i i
(7)
and the probability for a coalescent in the sample with
the disease is
r (T  t )D i iP = .disease coalescent r (T  t ) r (T  t ) r (T  t )W i i D i i M i i
(8)
Thus, given a scenario about the demographic devel-
opment of a population, this approach generates a ge-
nealogy of a sample of wild-type and disease chromo-
somes with respect to the population history.
The coalescent approach makes it possible to study
the potential to locate a single locus that contributes to
a complex disease—for example, a multilocus disease.
The genealogy of a complex disease is simulated by as-
suming that a proportion p1 of the individuals showing
the disease are genotypically wild types at the locus of
interest. Thus, a sample of nD affected individuals is a
mixture of p1nD wild-type alleles and disease(1 p )n1 D
alleles at that specific locus.
Similarly, one can imagine that, in a sample of indi-
viduals showing the wild-type phenotype, a proportion
p2 of them are carrying a disease allele at the specific
locus but that the disease either is not manifest at the
time of the study or has only low penetrance. Thus, a
sample of nW individuals comprises true wild-(1 p )n2 W
type alleles and p2nW disease-allele carriers.
If p1 and p2 are known, then the construction of the
genealogy is carried out by adjusting the sample sizes
for the simulations; that is, the wild-type sample has size
and the disease sample has size′n = (1 p )n  p nW 2 W 1 D
. Once the genealogy is built,′n = p n  (1 p )nD 2 W 1 D
p1nD individuals from the -simulated wild types are
′nW
randomly assigned to the simulated sample of individ-
uals who show the disease. And, vice versa, p2nW indi-
viduals of the simulated sample of affected individuals
are assigned to the simulated wild-type sample. Thus,
the genealogy reflects the true relationship among the
individuals in the sample, and the reshuffling process
after each simulation mimics the uncertainty of a correct
assignment to the two categories.
Evolution of the SNP
Once a genealogy is specified, the evolution of SNPs
is superimposed on the genealogy. The goal of this ex-
ercise is to obtain a sample of wild-type and disease
chromosomes, in which each chromosome is associated
with a haplotype of SNPs.
Consider a collection of l diallelic markers (SNPs)
where defines the (allelic) state of1,2,) l, s  {0,1}i
marker i. We assume that markers are ordered along the
chromosome where the disease gene is located, marker
1 being next to the gene, marker 2 being second closest,
and so on. All the markers are located downstream of
the disease locus of interest. The set comprises alll{0,1}
2l haplotypes that can be constructed from the markers.
Thus, a haplotype of markers constitute a (0,1) sequence
of length l.
Let be the stationary frequency ofP = [p (0),p (1)]i i i
marker and let be theli(i = 1,) ,l), L = {l(s) : s  {0,1} }
stationary distribution of marker haplotypes in the pop-
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Figure 3 LD distribution between the marker (SNP) and the disease gene for the CONST model. The markers were 5, 50, and 100 kb
away from the disease gene or were unlinked.
Figure 4 Power of a single SNP to detect significant LD, as function of distance (recombination rate) to the disease gene. Populations
either were CONST or were REC-EXP or OLD-EXP.
ulation. By assignment of the haplotype frequencies, the
LD between the marker loci is set.
Furthermore, mi defines the mutation rate (per gen-
eration) of marker i, and specifies the recombinationri,i1
rate (per generation) between marker i and , wherei 1
is the (allelic) state of the disease locus ofs  {W,D}0
interest. To simulate evolution of mutation and recom-
bination events, each branch length of the genealogy is
rounded to the next smallest integer.
The state of the markers at the MRCA is determined
by drawing randomly from the haplotype distribution
L. If a mutation occurs at marker i, the current state of
the marker mutates to the remaining state. A single re-
combination between markers i and replaces thei 1
current haplotype by another haplotype(s ,s ,) ,s )i1 i2 l
randomly chosen from the corresponding equilibrium
distribution—that is, the probability to select haplotype
equals(s ,) ,s )i1 l
Pr[(s ,) ,s )] = l(k ,) ,k ,s ,) ,s ) . (9)i1 l 1 i i1 l
i(k ,),k ){0,1}1 i
If exactly k recombinations occur and if recombination
happens immediately downstream of thej  {1,) ,k}
site and then the hap-i  {1,2,) ,l} i ! i ! i ) ! i ,j 1 2 3 k
lotype segments ,(s ,s ,) s ) (s ,s ,) ,s ,s ),i i 1 i 1 i i 1 i i 11 1 2 3 3 4 4
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Figure 5 Empirical LD distributions between a 4-allelic marker (i.e., haplotypes were reconstructed from two SNPs) and a disease gene
in a CONST population. The SNP distances of the markers closest to the disease gene were 5, 50, or 100 kb.
and so forth are exchanged for a segment from the cor-
responding distribution of haplotypes—that is, equation
(9) is modified accordingly. The whole process is re-
peated until the state of the markers at the next branch-
ing point of the genealogy is determined.
The outcome of the simulation is a set of n  nW D
haplotypes consisting of nD disease genes and their
marker haplotypes and of nW wild-type haplotypes. This
set constitutes a random sample of the distribution of
the marker alleles in the sample of wild-type chromo-
somes and disease-carrying chromosomes, conditional
on the genealogy.
On the basis of this sample, the amount of LD, d, is
calculated for the haplotypes. Let hW(s) and hD (s) be the
frequencies of haplotype in the wild-type sam-ls  {0,1}
ple and the disease-carrying sample, respectively; then,
2[ ]d =  h (s) h (s) . (10) W D
ls{0,1}
Note that d takes a value between 0 and , the latter2
being obtained when the wild-type chromosomes and
the disease chromosomes are fixed for different SNP hap-
lotypes. The properties of d are well known (Nei 1987).
Simulation Conditions
So far, we have not specified the simulation conditions.
First, we need to define the demographic history of the
population, to build a genealogy. We define a class of
population histories that starts with a given number of
chromosomes, N(0), and that shrinks exponentially
while going backward in time until time t (Weiss and
von Haeseler 1998). From that point onward, the pop-
ulation remains constant, at a size of . With[N(0)] /r
these parameters, N(t), the number of chromosomes at
time t, is defined as
N(0) if r = 1
t
N(0)r if r( 1 and t ! ttN(t) = .
N(0){ if r( 1 and t  t
r
The influence of three population histories on the
amount of LD is studied. The first model, CONST, as-
sumes a constant population of 20,000 chromosomes.
The second scenario, which uses a population that ex-
panded a long time ago (OLD-EXP), supposes a pop-
ulation of current size of chromosomes, rep-912# 10
resenting an autosomal locus in a population of 6 billion
people. It started to grow generations ago,t = 2,800
from a population of 20,000 chromosomes—that is,
. Thus, the Paleolithic expansion is modeled.5r = 6# 10
The third case, which uses a population that expanded
recently (REC-EXP), assumes that the population started
to grow, as a result of the agricultural revolution, from
an initial 20,000 chromosomes in the recent past (t =
) to its present size of chromosomes. The9550 12# 10
disease:wild-type ratio is set to .f = 1.0
Experiments were carried out for marker orl = 1 l =
markers. If the recombination rate between2 l = 2,
markers was equal to which is the range5r = 3# 10 ,12
over which SNP haplotypes can be typed with one PCR.
To study the influence of population history on the
amount of LD, we simulated a sample of wild-n = 200W
type chromosomes and affected chromosomes.n = 200D
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Figure 6 Average LD between an SNP and a disease gene, as a function of the mutation rate of the disease gene and three population
histories: CONST, REC-EXP, and OLD-EXP. The distance between the disease gene and the marker is 10 kb, the sample consists of 200 affected
and 200 wild-type chromosomes, and the frequency of the disease allele is .5.
The mutation rate of each marker, as well as that of the
disease locus, was set to 106/locus/generation. This rate
is reasonable for the disease locus; the mutation rate of
an SNP does not affect our results as long as it is smaller
than the recombination rate (data not shown). For sim-
plicity, we further assumed that for eachP = (.5,.5)i
marker i and that —that is, theL = (.25,.25,.25,.25)
marker loci are in linkage equilibrium. The recombi-
nation frequency varies between and 103, in55# 10
increments of 55# 10 .
The influence of the disease:wild-type ratio on equa-
tion (10) was investigated by changing f from
to thereby fixing the recom-.01,.02,) ,.1 .1,.2,) ,1.0,
bination rate to 104, whereas the rest of the simulation
conditions remained unchanged.
We also examined the effects of different mutation
rates at the disease locus. Hence, the rate varied between
107 and 103/locus/generation, and the recombination
rate was set to 104.
To analyze the effect of incomplete genotype-pheno-
type correlation, p1 was varied over For each0,.1,) ,.9.
choice of parameters, 1,000 genealogies were generated
and the relevant statistics were computed.
Results
For most of our work, we compared LDs derived from
a CONST population with LDs obtained from expand-
ing populations that started to grow at some well-defined
point t in the past. As can be expected, the simulation
results with respect to d and the probability of finding
significant LD showed a different picture for OLD-EXP
and REC-EXP populations versus a CONST population.
Moreover, the amount of LD as defined in equation (10)
obviously depends on the rate of recombination between
marker locus and disease locus. This observation was
virtually independent of the details of the population
history. For the sake of clearness, the recombination rate
was converted to distances (in kb), following the con-
vention that 1 cM corresponds to 1 Mb. In other words,
1 kb amounts to a recombination rate of 105.
Single Diallelic Markers
If only one diallelic marker (SNP) is considered, then
the amount of LD (see fig. 2) declines rapidly as the
marker moves farther away from the disease gene. Figure
2 also shows that most information, in terms of d, is
lost within the first 5 kb away from the disease locus.
If the marker is 5 kb away, then, irrespective of the
population history, the average d value decreases to
∼37% of the theoretically maximal value of ford = 2
a single SNP. For distances 15 kb, the decline of d de-
pends on the population history. t (the time when the
expansion started) governs this decline. A population
with a small t value (i.e., a REC-EXP population) be-
haves, by and large, like the CONST model. The LD
between marker and disease locus decreases at an in-
termediate rate between that of the CONST simulation
and that of the OLD-EXP simulation. In a CONST pop-
ulation, the average d value monotonically decreases
from .56, for a closely linked marker (5 kb), to .19, for
a marker 100 kb away. A value of .057 was estimated
for an unlinked SNP, which was already achieved for
the OLD-EXP model for recombination distances 185
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Table 1
Average Number of Mutations for Different Mutation Rates and Different Disease Frequencies
(Prevalences) and Population Structure
POPULATION HISTORY
AND PREVALENCE
MUTATION RATE PER GENE AND GENERATION
107 106 105 104 103
CONST:
.5 1.01 .11 1.12 .36 2.11 1.05 9.72 2.76 48.37 5.45
.05 1.00 .03 1.01 .11 1.11 .35 2.11 1.04 9.74 2.74
REC-EXP:
.5 1.02 .15 1.22 .51 3.14 1.48 19.48 4.05 118.69 7.56
.05 1.01 .11 1.14 .32 2.05 1.40 11.35 3.07 84.79 7.18
OLD-EXP:
.5 1.06 .25 1.62 1.00 6.93 2.57 52.60 6.41 195.54 2.53
.05 1.04 .21 1.42 .76 5.29 2.01 40.44 5.67 185.78 4.62
kb. Thus, in a growing population, the potential infor-
mation about allelic association between a disease allele
and a marker is rapidly lost.
Although the mean d values give some idea about the
factors generating LD, it is more insightful to study the
(simulated) distribution of d values for different recom-
bination rates, to evaluate the potential usefulness of an
SNP for mapping attempts. Figure 3 displays the results
in a CONST population for a marker not linked to the
disease gene and for markers that are 5, 50, and 100 kb
away from the disease locus. All distributions show a
maximum at and decrease as d increases. Al-d = .1
though the probability to observe a d value 1.4 is !.001
for an unlinked marker, even for remotely linked mark-
ers—for example, 100 kb away—the probability to ob-
serve d values 1.4 is not negligible. The d distribution
for a marker closest to the disease gene (5 kb) extends
over the whole range of possible d values; the resulting
distribution appears to be almost uniform across the
range of possible d values. Very much the same picture
emerges if the scenarios OLD-EXP and REC-EXP are
analyzed. However, the probability of finding large d
values is even smaller than that in the CONST scenario
(data not shown).
The simulated distributions for a marker a given dis-
tance away and an unlinked marker allow an analysis
of the power to detect significant association. The dis-
tribution of the unlinked marker serves as the null hy-
pothesis (H0), and the distribution of a marker some
distance away from the disease locus represents the al-
ternative hypothesis (H1). From these distributions, it is
straightforward to construct power curves—that is, the
probability of detecting a significant association for a
marker a fixed distance away from the disease locus.
Figure 4 shows the resulting power curves based on a
single SNP for the CONST, REC-EXP, and OLD-EXP
scenarios. The significance level was set to . Thisa = .005
level is apt for an experimental design in which 10 dis-
ease-candidate genes are analyzed with 10 independent
markers. The multiple tests carried out for each potential
candidate gene would then lead to a nominal significance
level of 5%. The significance level chosen here may be
a bit too liberal, but, for the sake of argument, we have
adopted this value, following standard statistic proce-
dures. For a real study, the significance level should be
adjusted according to the costs involved when one is
making an incorrect declaration of association. In such
situations, is probably more appropriate.a = .0001
However, if the distance of the marker to the disease
gene is ∼5 kb, then the probability of detecting a sig-
nificant linkage is ∼73% in the CONST and REC-EXP
scenarios. The power to detect association drops quickly
as the distance between the marker and the gene in-
creases. A marker 100 kb away from the disease locus
has only a 32% chance to suggest association if the
population size is constant. In an expanding population,
the power drops more quickly, again dependent on t,
the time when expansion started. In the OLD-EXP pop-
ulation, the power falls to !10% if the distance between
marker and disease locus is 140 kb. For a REC-EXP
population, the decline in power is less pronounced.
Haplotypes as Marker
Although the detection of LD when only one diallelic
marker is used appears to be difficult or restricted to
situations in which the marker is in very close association
with the disease gene, microsatellites having more than
two alleles have been successfully employed to show high
amounts of LD (Laan and Pa¨a¨bo 1997). From this per-
spective, it is interesting to study the potential to detect
a significant association if more than one SNP is used.
Hence, we carried out simulations for the CONST, REC-
EXP, and OLD-EXP scenarios under the assumption that
we can construct haplotypes from two SNP markers that
are close to each other (see the Simulation Conditions
subsection, above). From two SNP we can construct four
haplotypes, which allows the computation, according
to equation (10), of the d value. The simulation indicates
that the mean d value, as a function of the distance
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Figure 7 Average LD between an SNP and a disease gene if the prevalence varies and population histories (CONST, REC-EXP, and OLD-
EXP) are different. The distance between the disease gene and the marker is 10 kb, the sample consists of 200 mutant and 200 wild-type
chromosomes, and the mutation rate of the disease locus is 106. The vertical line marks a change in scale on the horizontal axis.
between marker and disease locus, is always larger than
the corresponding value for a single SNP (data not
shown).
More impressive is the change in the shape of the
distribution of d values for markers at selected distances
from the disease gene (see fig. 5). Although the distri-
butions in the one-SNP case monotonically decreased,
the distributions are now bell shaped, with the exception
of the distribution for an unlinked marker; the latter
distribution is similar to that of a single SNP. The shape
of the distribution and the movement of the mode are
already indications that it should be easier to detect as-
sociation. Thus, the power to detect significant associ-
ation is substantially enhanced. Using, again, a signifi-
cance level of we estimate a power of 95% ina = .005,
the CONST scenario for the 5-kb marker. This power
drops to 69% for the 100-kb marker. Also, in expanding
populations (i.e., REC-EXP and OLD-EXP), the power
is as high as 92% for the 5-kb marker, but, at a distance
150 kb, it quickly drops to 10% for the OLD-EXP model
and stays 135% for the REC-EXP model.
Thus, a marker system with more than two alleles or
haplotypes is much more efficient in pinpointing any
significant association. These results are corroborated by
empirical and theoretical analysis (Ott and Rabinowitz
1997; Terwilliger et al. 1998; Kruglyak 1999).
Multiple Disease Alleles
An important question in association studies relates
the number of alleles that result in the disease phenotype.
In common diseases, it is likely that different alleles in
the same gene cause the same disease phenotype. The
classification based on the disease phenotype does not
result in the identification of a single allele at the disease
locus.
Therefore, the disease carriers are not necessarily iden-
tical by descent (IBD). Since our model has not incor-
porated an IBD assumption, we studied the influence
that different alleles leading to the same phenotype have
on the average d value. To carry out simulations with
more disease alleles, we simply increased the mutation
rate of the disease gene, assuming that each mutation
leads to a new disease-causing allele. Again, we do not
specify when these mutations occur. However, we require
that the recombination rate between the marker and
every disease-causing allele is the same; that is, mutations
leading to a disease phenotype should be close to each
other—for example, on one recombinational unit.
Figure 6 shows the change in d values as the mutation
rate increases. Irrespective of the population history, a
high mutation rate causes a smaller d. If the mutation
rate is 1105, we observe a dramatic decline in the d
value. Still, in a CONST population, the average d value
is always larger than the corresponding value for the
OLD-EXP and REC-EXP populations. The d value for
REC-EXP is between the d values for CONST and OLD-
EXP. Again, the behavior of d depends on the time t
when the expansion started.
To assist in the understanding of this result, table 1
displays the average number of mutations that lead to
a disease allele, for the three population histories. Most
important is the transition from a mutation rate of 105
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Figure 8 Average d values between an SNP and a disease gene, for varying percentages of chromosomes with disease phenotype and
wild-type genotype (p1). The effect of this misclassification is shown for different population histories (CONST, REC-EXP, and OLD-EXP). The
distance between the disease gene and the marker is 10 kb, the sample consists of 200 mutant and 200 wild-type chromosomes, the frequency
of the disease allele is .5, and the mutation rate of the disease locus is 106.
to one of 104. If the mutation rate equals 105, then
the number of mutations and the number of different
disease alleles, although high, do not lead to a substantial
decrease in the d value. If the mutation rate is increased
by a factor of 10, then the number of mutations increases
approximately fivefold. This large number of mutations
decreases the d value drastically.
In OLD-EXP and REC-EXP populations, the same
mutation rate generates more disease alleles with de-
scendants in the sample than it does in a CONST pop-
ulation. But, because the population is expanding and
the genealogy after expansion shows a more or less star-
like shape (Slatkin and Hudson 1991), mutations (up to
six) that occur during expansion are most likely to affect
a single chromosome in the sample and do not dra-
matically influence the d value that is generated by the
old disease allele in the sample. But, if too many mu-
tations occur, the resulting disease-carrying haplotypes
share no common history, and they cannot show a high
d. For example, if the mutation rate equals 103, then
the d value for the OLD-EXP population equals the
value observed for an unlinked marker, thus reflecting
the fact that almost every disease carrier exhibits its pri-
vate allele. In a CONST population, the situation is dif-
ferent. If a mutation has occurred, the mutation is likely
to give rise to a disease allele that is represented more
than once in the sample. Thus, although different alleles
cause the disease, each disease allele occurs frequently
in the sample. Accordingly, it takes fewer disease alleles
for a similar reduction in LD. But, because expanding
populations also accumulate a greater number of dif-
ferent disease alleles, chances are still higher to detect
significant association in a CONST population, even
when the mutation rate is high.
The number of disease alleles that can exist while still
showing a large d value is surprisingly high. For ex-
ample, in the case of the OLD-EXP scenario, if the mu-
tation rate equals 107, then the disease gene is almost
always IBD, with an average of If the mutationd = .453.
rate is increased by a factor of 100, then we observe,
on average, seven disease-causing alleles, but the d value
is reduced to only .424.
Influence of the Prevalence of the Disease
So far, we have assumed that the disease allele has an
extremely high occurrence, of 50%. In this section, we
analyze the influence of f, the relative frequency of the
disease-carrying chromosome, on the d value for three
population histories.
Figure 7 shows the results of the simulations. As the
ratio of disease phenotype to wild-type phenotype in-
creases, the average d value decreases, and, therefore,
the power to suggest association is reduced. Thus, as-
suming that disease and wild-type chromosomes occur
at the same frequency actually results in the worst-case
scenario. This effect is substantially less pronounced in
the OLD-EXP scenario. Although the d value is still
higher with lower f, the effect is small. This suggests
that OLD-EXP populations are least suitable for the
mapping of rare diseases. The effect of prevalence on
the expected number of mutations that generate disease
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Figure 9 Distribution of LD between fictitious marker-and-gene pairs, for the LPL data (Clark et al. 1998; Nickerson et al. 1998), that
are 1, 5, and 8 kb apart. For details, see the text.
alleles can be seen in table 1. In the CONST scenario,
especially, a low prevalence reduces the number of mu-
tations substantially.
Other Factors Influencing the Detection Probability
So far, we have discussed the behavior of the d value
between one locus that carries disease-causing alleles and
the SNP. To account for more-complex situations, with
genotype-phenotype correlation !1, we simulated a sam-
ple in which p1nD individuals showing the disease phe-
notype are carriers of the wild-type allele at the locus of
interest. In real data, this might occur either if multiple
genes can cause the disease or if the disease phenotype
also has nongenetic causes. In the later case, p1 is, for
example, the frequency of individuals who developed
the disease because of environmental factors.
As explained in the Methods section, it is straight-
forward to build this model into the simulations. Figure
8 shows the result of this on the average d value, as a
function of p1, the proportion of wild-type alleles falsely
assigned to the disease-showing group. Note that the
case in which reflects the simulations that we havep = .01
carried out so far. With increasing p1, the average d value
drops almost linearly, irrespective of the population his-
tory. If then the average d is close to the valuep = .9,1
for unlinked markers. Thus, complex diseases add an
additional difficulty in the localization of disease genes.
This result is, of course, not surprising, but the simu-
lations carried out here allow us to add a quantitative
component.
The effect of low penetrance or late onset on the av-
erage d value is similar to the effect in complex diseases
studied above. In this case, one simply assumes that p2nW
individuals who are carrying the disease allele do not
exhibit the phenotypic features of the disease and are
therefore classified as wild type.
An Illustrative Example
Simulation studies include simplifications that cannot
always be maintained for real data. To verify the basic
idea of our approach, we analyzed sequence data from
a population-genetic study of the human lipoprotein li-
pase gene (LPL [Clark et al. 1998; Nickerson et al.
1998]. However, we should be aware that the LPL data
were generated for different purposes; therefore, the re-
sults are not directly comparable to the simulated results.
On the other hand, the analysis gives some qualitative
insights into what to expect from real data.
The data set consists of 61 SNPs in which each allele
occurs at least three times in the sample. Each of these
SNPs was treated as a putative disease gene; one state
of the SNP was considered to be a disease-causing allele,
and the alternative state was defined as the wild type.
The remaining SNPs were used as markers. For marker-
and-gene pairs that are physically ≈1 kb (637 pairs), ≈5
kb (424 pairs), or ≈8 kb (166 pairs) apart, the resulting
d value was computed. As was also observed under the
idealized simulation conditions, the average d value for
the LPL data decreases to .49 (at 1 kb), .33 (at 5 kb),
or .27 (at 8 kb).
The distribution of d values resulting from this type
of data analysis is displayed in figure 9. The shape of
the resulting curves resembles our simulation results (see
fig. 3). However, we count more marker-and-gene pairs
with d values !.1 than are predicted by the correspond-
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Figure 10 Distribution of d values for the LPL data and for a recently expanding population (REC-EXP), when markers are 15 or 20
kb away from the disease gene. Distributions are based on the haplotypes derived from two SNPs.
ing 5-kb simulation. Therefore, it is much more difficult
to detect a significant association in this sample. This
observation suggests that the physical distance does not
reflect the true recombination rate, which is supposedly
higher and therefore might indicate the existence of a
hotspot of recombination.
To investigate this phenomenon further, we con-
structed haplotypes from two SNPs that were close to-
gether (!5 kb apart) and were ∼5 kb away from the
putative disease gene (7,090 trios). The resulting distri-
bution of d values is displayed in figure 10, together
with the simulated distribution of a marker 15 or 20 kb
away from the disease gene in a REC-EXP population.
The average d value of .47 for the LPL analysis falls
between the averages from the two simulations, which
are .49 and .44 for the 15- and 20-kb cases, respectively.
Moreover, among the three scenarios studied, the d-
value distribution of a REC-EXP population with a
marker pair 15 kb away from the disease gene shows
the best least-squares fit to the empirical LPL d-value
distribution, whereas the least-squares fit for an OLD-
EXP population is substantially worse. Thus, when all
due caution is observed, it appears that a recombina-
tional hotspot is hidden somewhere in the LPL gene,
which causes the average d value to be similar to the d
value that we obtain from simulated markers 15 and 20
kb away from the gene. Moreover, a simple least-squares
fit indicates that the individuals from the LPL sample
are reasonably well described by a REC-EXP popula-
tion. However, we did not explore the full complement
of possible population histories, and, therefore, the anal-
ysis, although promising in its own right, must be viewed
with great care.
Discussion
Our results indicate the complexities involved in at-
tempts to map common disease genes. We performed
various simulation studies to investigate the effect that
(a) distance (recombination rate) between the marker
and the locus of interest, (b) population histories, (c)
mutation rates, (d) prevalences of the disease, and (e)
complex diseases have on the amount of LD. Our anal-
ysis, although by no means complete, indicates that the
influence of population history on the d value is most
substantial. A CONST population always leads to a
higher chance of detection of significant association, if
the other parameters are unchanged. However, even for
a CONST population, the power of our method to com-
pute the haplotype-distribution differences between
wild-type and mutant groups is not impressively high
except when the marker (SNP) is close (≈5 kb). Thus,
it is quite difficult for a diallelic-marker system to locate
a disease gene unless the human genome is closely
packed with markers. Especially in OLD-EXP and REC-
EXP populations, significant association over long dis-
tances is rare, as also has been observed by others (Slat-
kin 1994; Kruglyak 1999). In other words, on the basis
of the average mammalian-gene length of 17 kb (Lewin
1994), one SNP per gene does not suffice for detection,
with a high probability, of significant linkage. Thus, it
is necessary to assess more than one marker per gene.
On the other hand, this approach quickly raises the mul-
tiple-hypothesis–testing issue.
Although, at a significance level of .005, respectable
power is achievable if the marker and the disease gene
are closely linked, a whole genome scan with 100,000
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SNPs requires a significance level of if it is to75# 10
result in a P value, for the first-order statistic, of ∼5%.
The power loss associated with such high levels of sig-
nificance makes such attempts futile. Attempts that con-
sider LD information from all markers simultaneously
are more likely to be successful in such a situation, al-
though the multiple-testing problem remains for these
approaches. A possible way to proceed has been pro-
posed by Wiuf and Donnelly (1999). Another sensible
strategy is the application of our test procedure to a
collection of markers in the vicinity of a set of candidate
genes. However, the problem of multiple testing is re-
duced if haplotypes can be used as markers. We show
that it is more sensible to reconstruct haplotypes from
two or more SNPs. If this is possible, the power is sub-
stantially enhanced.
Our simulations deal mostly with the situation in
which the prevalence of the disease in the population
equals 50%. As has been shown, this is the worst-case
scenario. If the prevalence drops to 10%, then the
probability to detect significant association is increased.
For example, the average d value for a disease with a
frequency of 10% and 10 kb away from the marker is
larger than the d value for a disease with a frequency
of 50% and 5 kb away from the marker. Thus, it seems
easier to locate common diseases that occur at frequen-
cies of 10% in the population. On the other hand, on
the basis of our simulations, the optimism that a case-
control study with a complete map of SNPs that co-
ver the entire human genome can provide an easy way
to map complex diseases is not justified. Thus, our re-
sults corroborate results from a similar study (Kruglyak
1999).
Our simulations show that, in more-complex
cases—for example, if more than one gene causes the
phenotype of interest and, therefore, many people car-
rying a wild-type gene at one locus of interest are clas-
sified as disease carriers—the LD will be further reduced.
In such situations, it is much harder to detect a haplo-
type-distribution difference between wild-type and mu-
tant individuals.
Further difficulties arise from the assumption of a
demographic history of the population, which is gen-
erally not known and is difficult to infer. To overcome
this problem, one strategy might be to infer the popu-
lation history by using a coalescence-based approach
(Griffiths and Tavare´ 1994a, 1994b; Kuhner et al. 1995;
Weiss and von Haeseler 1998)—by analyzing, for ex-
ample, either data from mitochondrial hypervariable
regions I and II, which are known from worldwide pop-
ulation studies (Burckhardt et al. 1999), or data from
other genomic regions, such as variation in either the Y
chromosome (Hammer et al. 1997) or the Xq13 region
of the X chromosome (Kaessmann et al. 1999). More-
over, the analysis of more than one genomic region, in
order to elucidate the demographic history of a popu-
lation, may help to reduce the large confidence intervals
associated with a coalescence-based approach. Never-
theless, once the history is more or less unraveled, the
methods outlined here may be applicable to the inference
of which conditions are most promising for a disease of
interest, to justify a mapping attempt in a population.
Our simulations are based on a great many simplifi-
cations, which need to be carefully considered in a real
application. However, the LPL analysis shows that, on
a qualitative level, the behavior of the d value bears
similarities to that in the simulation studies. But, on a
more quantitative level, deviations are, in fact, substan-
tial. One reason for these deviations is the nonuniform
distribution of SNP-allele frequencies in the LPL data,
which reduces the probability of a high LD. In our sim-
ulation, we assume a 1:1 ratio of SNP alleles, which is
not always true in the LDL data. Moreover, the relatively
small sample size of 71 individuals (Clark et al. 1998;
Nickerson et al. 1998), as well as the fact that d values
derived from the different marker-and-gene pairs are not
truly independent measurements, contributes to the ob-
served discrepancy.
Comparing, in a REC-EXP population, the empirical
d distribution for 2-SNP haplotypes that are 5 kb away
from a putative disease locus, we observed that the av-
erage d value of the LPL data falls between the averages
observed for 2-SNP haplotypes that are 15 or 20 kb
away from the disease locus. Thus, it seems plausible
that the physical distance does not reflect the true re-
combination rate. This estimate is also interesting from
an evolutionary point of view, because the result alludes
to a recent expansion of humans. This observation cer-
tainly deserves a more exhaustive investigation. It would
be desirable to develop a method that is based on the
approach pursued here, in order to estimate the true
recombination rate between a large sample of popula-
tion-based sequences. Finally, the fact that our simpli-
fying assumptions provide a reasonable description of
real data raises hope that our simulations will put us in
the position to model the evolution of LD for other
population histories and marker configurations.
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